Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C Dodgson

Adenovector Engineered Interleukin-2 Expressing Autologous Plasma Cell Vaccination After High-Dose Chemotherapy for Multiple Myeloma - A Phase 1 Study

Leukemia

English

Related publications

Aggressive Neoplastic Plasma Cell Growth With MLL Gene Rearrangement After High-Dose Therapy With Autologous Stem Cell Support for Multiple Myeloma

Bone Marrow Transplantation

Transplantation

Hematology

2001

English

High-Dose Chemotherapy and Autologous CD34-positive Blood Stem Cell Transplantation for Multiple Myeloma in an HIV Carrier

Bone Marrow Transplantation

Transplantation

Hematology

2002

English

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia

English

High-Dose Therapy and Autologous Stem Cell Transplant in Older Adults With Multiple Myeloma

Bone Marrow Transplantation

Transplantation

Hematology

2015

English

Infectious Complications After High-Dose Chemotherapy and Autologous Stem Cell Transplantation: Comparison Between Patients With Lymphoma or Multiple Myeloma and Patients With Solid Tumors

Bone Marrow Transplantation

Transplantation

Hematology

2001

English

Severe Autologous GVHD After Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma

Bone Marrow Transplantation

Transplantation

Hematology

2008

English

Amifostine Reduces High-Dose Melphalan Induced Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplant (HCT) for Plasma Cell Myeloma

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Autologous Stem Cell Transplantation Followed by Consolidation Chemotherapy for Patients With Multiple Myeloma

Bone Marrow Transplantation

Transplantation

Hematology

2005

English

Long-Term Follow-Up of Idiotype Vaccination in Human Myeloma as a Maintenance Therapy After High-Dose Chemotherapy

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C Dodgson

Adenovector Engineered Interleukin-2 Expressing Autologous Plasma Cell Vaccination After High-Dose Chemotherapy for Multiple Myeloma - A Phase 1 Study

Related publications

Aggressive Neoplastic Plasma Cell Growth With MLL Gene Rearrangement After High-Dose Therapy With Autologous Stem Cell Support for Multiple Myeloma

High-Dose Chemotherapy and Autologous CD34-positive Blood Stem Cell Transplantation for Multiple Myeloma in an HIV Carrier

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

High-Dose Therapy and Autologous Stem Cell Transplant in Older Adults With Multiple Myeloma

Infectious Complications After High-Dose Chemotherapy and Autologous Stem Cell Transplantation: Comparison Between Patients With Lymphoma or Multiple Myeloma and Patients With Solid Tumors

Severe Autologous GVHD After Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma

Amifostine Reduces High-Dose Melphalan Induced Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplant (HCT) for Plasma Cell Myeloma

Autologous Stem Cell Transplantation Followed by Consolidation Chemotherapy for Patients With Multiple Myeloma

Long-Term Follow-Up of Idiotype Vaccination in Human Myeloma as a Maintenance Therapy After High-Dose Chemotherapy